Solesence, Inc. projected revenue of $35 million [1] for the second half of 2026 during its second-quarter earnings conference call.
The financial guidance comes as the company seeks to diversify its product offerings and resolve internal accounting hurdles. These strategic shifts are intended to stabilize growth and expand the company's footprint in the personal care market.
President, CEO and Director Kevin Cureton and Chief Financial Officer Laura Riffner led the call on Wednesday, Aug. 19 [2]. The virtual meeting took place at 5 p.m. ET [3] to present the company's financial results and outline upcoming initiatives.
During the presentation, leadership announced an expansion into scalp-care products. This move marks a strategic pivot to broaden the company's catalog beyond its existing lines. The company, which is headquartered in Romeoville, Illinois [4], is positioning this expansion as a key driver for future revenue.
Alongside the growth plans, the company addressed ongoing inventory-costing issues. These challenges have impacted how the company tracks and values its stock, though leadership said these hurdles are part of their broader management strategy for the remainder of the year.
The Q2 2026 report serves as a benchmark for the company's performance as it enters the final six months of the year. The $35 million [1] target reflects the company's expectations for sales volume and market penetration through the end of December.
“Solesence projected revenue of $35 million for the second half of 2026.”
The combination of a specific revenue target and a move into scalp-care suggests Solesence is attempting to offset internal operational frictions—specifically its inventory-costing issues—with aggressive product diversification. By expanding its category reach, the company is betting that new market segments can drive the growth necessary to meet its second-half financial projections.
